What this medicine is commonly used for
Commonly requested where oncology or specialty protocols require methotrexate formulations consistent with local labeling.
Informational only. Treatment decisions belong to qualified clinicians and to local labeling.
Shortage and sourcing context
Methotrexate shortages have affected tablets and injectable presentations at different times. Substitution decisions are clinical and regulatory.
How it is presented
Examples of presentations referenced for this medicine. Actual market presentations vary by country and registration, so check the pack in front of you.
- Tablet
- Injection
Strength examples 2.5 mg, 25 mg/mL (examples)
Who typically asks us about this medicine
- Patients and families who cannot fill a prescription locally
- Hospital pharmacies managing formulary access during a shortage
- Clinics with defined treatment pathways and continuity of care
- Procurement teams coordinating licensed cross-border sourcing
Frequently asked questions
Full reference text(expand)
Antimetabolite therapy used in oncology and, in other settings, under distinct protocols and monitoring.
What this medicine is commonly associated with
Commonly requested where oncology or specialty protocols require methotrexate formulations consistent with local labeling.
Shortage and sourcing context
Methotrexate shortages have affected tablets and injectable presentations at different times. Substitution decisions are clinical and regulatory.
Procurement readers and documentation
Teams may attach formulary references, expected delivery windows, and importer details when permitted. This does not change clinical responsibilities.
Presentation examples
Dosage forms referenced on this page may include: Tablet, Injection. Strength examples may include: 2.5 mg, 25 mg/mL (examples). Actual market presentations vary by region and registration.
Important: This page is informational and not a substitute for professional medical advice, local labeling, or institutional protocols.